Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Reed

Showing results (631-640 of 715) with videos related to

Pageof 72
Sort By:
Science Translational Medicine|October 1, 2025
An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaquesL K Metthew Lam, Theron Gilliland, Matthew Dunn, et al.
Journal of Virology|July 26, 2013
Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaquesJ Pablo Jaworski, James Kobie, Zachary Brower, et al.
Plos Pathogens|March 13, 2020
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaquesGabriela M Webb, Jhomary Molden, Kathleen Busman-Sahay, et al.
Nature Communications|August 1, 2025
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodiesJulia Lederhofer, Andrew J Borst, Lam Nguyen, et al.
Plos Pathogens|November 10, 2016
Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus MacaquesBenjamin J Burwitz, Daniel Malouli, Benjamin N Bimber, et al.
Nature Communications|February 12, 2025
DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107Matthew P Morrow, Elisabeth Gillespie, Albert Sylvester, et al.
Plos Pathogens|January 8, 2016
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV InfectionGlen M Chew, Tsuyoshi Fujita, Gabriela M Webb, et al.
Plos One|April 29, 2026
Effects of hearing intervention on physical function: A secondary analysis of the ACHIEVE studyJennifer A Deal, Wuyang Zhang, Kening Jiang, et al.
JAMA Network Open|November 21, 2024
A Hearing Intervention and Health-Related Quality of Life in Older Adults: A Secondary Analysis of the ACHIEVE Randomized Clinical TrialAlison R Huang, Emmanuel Garcia Morales, Michelle L Arnold, et al.
Plos One|June 20, 2024
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret modelDouglas S Reed, Anita K McElroy, Dominique J Barbeau, et al.
Pageof 72

Showing results (631-640 of 715) with videos related to

Sort By:
Pageof 72
Science Translational Medicine|October 1, 2025
An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaquesL K Metthew Lam, Theron Gilliland, Matthew Dunn, et al.
Journal of Virology|July 26, 2013
Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaquesJ Pablo Jaworski, James Kobie, Zachary Brower, et al.
Plos Pathogens|March 13, 2020
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaquesGabriela M Webb, Jhomary Molden, Kathleen Busman-Sahay, et al.
Nature Communications|August 1, 2025
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodiesJulia Lederhofer, Andrew J Borst, Lam Nguyen, et al.
Plos Pathogens|November 10, 2016
Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus MacaquesBenjamin J Burwitz, Daniel Malouli, Benjamin N Bimber, et al.
Nature Communications|February 12, 2025
DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107Matthew P Morrow, Elisabeth Gillespie, Albert Sylvester, et al.
Plos Pathogens|January 8, 2016
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV InfectionGlen M Chew, Tsuyoshi Fujita, Gabriela M Webb, et al.
Plos One|April 29, 2026
Effects of hearing intervention on physical function: A secondary analysis of the ACHIEVE studyJennifer A Deal, Wuyang Zhang, Kening Jiang, et al.
JAMA Network Open|November 21, 2024
A Hearing Intervention and Health-Related Quality of Life in Older Adults: A Secondary Analysis of the ACHIEVE Randomized Clinical TrialAlison R Huang, Emmanuel Garcia Morales, Michelle L Arnold, et al.
Plos One|June 20, 2024
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret modelDouglas S Reed, Anita K McElroy, Dominique J Barbeau, et al.
Pageof 72